Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Adds Heart Disease Risk, Diabetes Warning to Prostate Cancer Drugs October 21, 2010 Staff Writers Add Your Comments Federal drug regulators are calling for new heart disease and diabetes warnings to be added to a class of prostate cancer drugs that includes Eligard, Lupron, Synarel, Trelstar, Vantas, Viadur, and Zoladex. On Wednesday, the FDA issued a drug safety alert, announcing that it was asking manufacturers to add the new warnings to all drugs belonging to a class known as gonadotropin-releasing hormone (GnRH) agonists. The warnings will alert patients and doctors that side effects of the drugs may include a small increased risk of diabetes and cardiovascular events, including heart attacks and strokes. The FDA launched a safety review of GnRH agonists in May. That review is ongoing. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Before the call for new label warnings, the FDA had already recommended that health care professionals be made aware of the potential risks and carefully weigh those risks before prescribing the drugs. The agency also recommended that patients prescribed a GnRH be monitored for diabetes and cardiovascular disease, and that cardiovascular risk factors, such as smoking and high blood pressure, be controlled while taking the medication. The FDA also warned patients not to stop treatment with GnRH’s unless instructed by their health care provider. GnRH’s suppress the production of testosterone, limiting the ability of prostate cancer to grow. The class of drugs includes Sanofi-Aventis’s Eligard, Abbott Laboratories’ Lupron, and Pfizer’s Synarel, among other brand names, as well as generic products. The drugs are also often used to treat women suffering from pain caused by endometriosis, and to treat anemia and breast cancer. It is also used in children to treat central precocious puberty. However, these uses have not been approved by FDA. The FDA estimates that there will be 217,730 new cases of prostate cancer among men this year, and that it will kill about 32,050 men, making it the second most common type of cancer among men in the U.S., behind skin cancer. Tags: Cancer, Diabetes, Eligard, Heart Attack, Heart Disease, Lupron, Pfizer, Prostate Cancer, Sanofi-Aventis, Stroke, Synarel, Trelstar, Vantas, Viadur, Zoladex More Lawsuit Stories Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” July 3, 2025 Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL July 3, 2025 JAK Inhibitors Could Increase Cancer Risks by as Much as 40%: Study July 3, 2025 2 Comments Petal November 11, 2010 Hello, My name is Petal J. from Trinidad. West Indies. I have had surgery in April 2008 for the removal of fibroid and my doctor insisted that I took the product Zoladex for six months. At the time I was 33 years old and I had gone thru menopause during the time I was taking the Zoladex. I had hot flashes, no period for six months etc. At present I am 35 years old and due to taking the product I have had rapid weight gain. I am 190 lbs fighting an obesity a problem I have never had before. All these things happened due to the fact that I have been injected for six months with the Zoladex product in 2008. Arthur October 23, 2010 I am a Bahamian. About a year ago I was advised that there was a tiny nodule on my prostate and my PSA level had risen to about 12. A biopsy performed in Orlando, Fla indicated Stage 2 cancer, which I was told was treatable. Prior to this, and starting radiation treatment, I was able to reduce the PSA count to 1.2 after using a suppository produced by a local urologist, Dr Joseph Evans, marketed under the brand name Navophos, although I was later informed that the active ingredient – afemale hormone- which I can’t recall at the moment, had been touted in a New York Times 1941 article as a breakthrough cure for cancer. At a local cancer forum, I was advised that “the cure” had been ordered withdrawn due to an association with heart attic susceptibility. On entering the local health system I was advised that I needed to switch to Zoladex in order to comply with eligibility requirements and also the fact that although ‘Navophos’ had been inquired about, it was not clear how it would impact the radiation treatment. After completing the radiation treatment, I was advised to have a new PSA test before a post-treatment assessment. However, at the time of the ‘post-treatment’ exam, I was advised that the result of the new PSA test had not been received and there would be no rectal exam as the effect of the radiation had probably left the area too sensitive for any ‘probing’, but I would be contacted about the results of the PSA test. After not being contacted after about three weeks I visited the local cancer radiation therapy centurion FridayOct 22 and was told the PSA test result had not yet been received and to check back the following week. Prior to this I visited my local GP and was told that my blood pressure, which had consistently been normal, was now somewhat lower. My occasional mild perspiring was attributed to ‘hot flashes’ as a result of the Zoladex. I am now awaiting the result of the PSA test. Another doctor has suggested that if it was him, he would have stayed on the Navophos even though it tended to leave one’s breasts in a somewhat ‘tender’ state. Apart from awaiting the results and any commentary about the PSA test, my next appointment with the radiation centre is in mid Jan 2011. Apart from the above, I still feel reasonably physically healthy. My urologist has advised that while the radiation therapy has an approximately 70% cure rate, additional hormonal therapy treatment increases this to about 90%. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: yesterday) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: yesterday) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 2 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: yesterday) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: yesterday) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 2 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)